[
  {
    "ts": null,
    "headline": "Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=82d152bb3291e4ec0edecfd243db82dc580f51038f20953601dfd15004868f8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744635610,
      "headline": "Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings",
      "id": 133908866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=82d152bb3291e4ec0edecfd243db82dc580f51038f20953601dfd15004868f8a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna : ECSMID 2025 (Mpox safety and immunogenicity)",
    "summary": "Safety and Immunogenicity of mRNA mpox Vaccine Candidate mRNA-1769: Interim Analysis Results from a Phase 1/2 trial Hiwot Hiruy,1 Rajeka Lazarus,2 Kieran McCafferty,3...",
    "url": "https://finnhub.io/api/news?id=0b90d778ccf5fbbe8807da85c2c65074b522a81aa879ef779bdfb91027253424",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744619813,
      "headline": "Moderna : ECSMID 2025 (Mpox safety and immunogenicity)",
      "id": 133906460,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Safety and Immunogenicity of mRNA mpox Vaccine Candidate mRNA-1769: Interim Analysis Results from a Phase 1/2 trial Hiwot Hiruy,1 Rajeka Lazarus,2 Kieran McCafferty,3...",
      "url": "https://finnhub.io/api/news?id=0b90d778ccf5fbbe8807da85c2c65074b522a81aa879ef779bdfb91027253424"
    }
  },
  {
    "ts": null,
    "headline": "Moderna : ECSMID 2025 (COVID immunogenicity of JN.1 and KP.2)",
    "summary": "Immunogenicity of JN.1- and KP.2- Encoding mRNA COVID-19 Vaccines Against JN.1 SARS-CoV- 2 Sublineages in Adult...",
    "url": "https://finnhub.io/api/news?id=6f80828ee3aeadd1cd038bfd5dea18bba9a694eca00d3c1c639aeea2e871ee4c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744619813,
      "headline": "Moderna : ECSMID 2025 (COVID immunogenicity of JN.1 and KP.2)",
      "id": 133906459,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Immunogenicity of JN.1- and KP.2- Encoding mRNA COVID-19 Vaccines Against JN.1 SARS-CoV- 2 Sublineages in Adult...",
      "url": "https://finnhub.io/api/news?id=6f80828ee3aeadd1cd038bfd5dea18bba9a694eca00d3c1c639aeea2e871ee4c"
    }
  },
  {
    "ts": null,
    "headline": "Moderna : ECSMID 2025 (COVID relative vaccine efficacy mRNA 1283 versus mRNA 1273)",
    "summary": "Relative Vaccine Efficacy of a SARS-CoV-2 Spike Receptor-binding and N-terminal Domain COVID-19 Vaccine Versus ...",
    "url": "https://finnhub.io/api/news?id=1dd1535a74a6cb1cac632a123ed7f059da7cb2cef4621a23200fc6d3c1c48567",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744619813,
      "headline": "Moderna : ECSMID 2025 (COVID relative vaccine efficacy mRNA 1283 versus mRNA 1273)",
      "id": 133906458,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Relative Vaccine Efficacy of a SARS-CoV-2 Spike Receptor-binding and N-terminal Domain COVID-19 Vaccine Versus ...",
      "url": "https://finnhub.io/api/news?id=1dd1535a74a6cb1cac632a123ed7f059da7cb2cef4621a23200fc6d3c1c48567"
    }
  }
]